Comprehend Systems Adds Rich Enz as Vice President of Quality Assurance

Comprehend Systems Adds Rich Enz as Vice President of Quality Assurance
Fast-Growing Clinical Data Analytics Company Strengthens Executive Team with Pharma Technology Industry Veteran from Teva Pharmaceuticals
October 16, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--With increasing number of sponsors and CROs looking to Comprehend Systems for cloud-based data analytics, visualizations and reporting, the company has named Rich Enz as vice president of quality assurance to support the development of pioneering cloud-based analytics tools. In addition to key industry contributions including the design of an award-winning clinical data management system, enterprise portal and CANDA system used by the FDA, Enz brings more than 35 years of experience driving research and development of large-scale clinical trials IT systems at companies like Covance, Inc., Integrated Clinical Systems and Teva Pharmaceuticals. Enz was also responsible for creating and validating one of the industry's first clinical data management systems, Sherlock, while at Covance.

    "Comprehend's approach to clinical data analytics is driving change in the industry in an entirely new way, at a time when it has become extremely critical for researchers at pharmaceutical and biotechnology companies to be able to quickly gain insights into their data in real-time"

"Comprehend's approach to clinical data analytics is driving change in the industry in an entirely new way, at a time when it has become extremely critical for researchers at pharmaceutical and biotechnology companies to be able to quickly gain insights into their data in real-time," said Enz. "As more and more research sponsors become comfortable with the security and performance of the cloud, I'm excited to join a company that's committed to making cumbersome, time-consuming and programmer-heavy clinical trial software deployments a thing of the past."

Prior to joining Comprehend, Enz served as associate director of application programming at Teva Pharmaceuticals, where he was responsible for SAS administration and maintaining a validated SAS programming environment in Teva's Global Branded Products division. Previously, Enz developed software at Integrated Clinical Systems. Enz also spent 15 years at contract research organization Covance, where, as senior director of clinical information technology, he provided technical oversight and architectural guidance to clinical IT staff and project teams. He also developed an international distributed database system at CIBA-Geigy, which is now part of Novartis.

"Along with years' worth of experience as a leading software developer in the clinical research space, Rich shares our vision of continuing to revolutionize the way clinical trials are conducted," said Rick Morrison, CEO of Comprehend Systems. "He will play a key role in supporting our leadership team and future product development as we continue to see increased traction with our cloud-based solution."

Tweet this: Pharma technology industry veteran Rich Enz joins @Comprehend Systems as VP of Quality Assurance http://bit.ly/WqC07j

About Comprehend Systems, Inc.

Comprehend Systems, Inc. (www.comprehend.com) offers clinical data visualization, analytics and reporting software that improves the way clinical researchers access, understand, explore and analyze data. Designed specifically for clinical researchers, Comprehend Clinical ™ enables data managers, monitors and clinical operations executives to identify broad operational and clinical trends across trials and also easily drill down and report on a wide range of factors, including safety issues, regulatory requirements and opportunities for critical time and cost savings. Comprehend Systems was founded in 2010 in Palo Alto by a team of entrepreneurs with decades of combined experience in clinical research and software development.

Contacts

for Comprehend Systems, Inc.
Susan McCarron, 617-986-5767
[email protected]

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.